Study shows Ozempic could help dialysis patients qualify for kidney transplants

Obesity is one of the biggest barriers preventing patients with end-stage kidney disease from receiving a life-saving kidney transplant. New research from Saint Louis University School of Medicine and SSM Health physicians reveals that breakthrough weight loss medications could change that—giving more patients a second chance at life.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup